Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
77.47 USD | +0.99% |
|
+10.59% | +149.98% |
10/07 | Goldman Sachs Raises Price Target on Insmed to $102 From $74, Maintains Buy Rating | MT |
09/07 | Guggenheim Adjusts Price Target on Insmed to $95 From $70, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+149.98% | 12.37B | |
+20.63% | 126B | |
+24.16% | 27.95B | |
-20.17% | 20.5B | |
-16.06% | 17.12B | |
-18.07% | 16.1B | |
-47.70% | 14.97B | |
+11.92% | 14.84B | |
+58.32% | 14.38B | |
-10.27% | 9.91B |
- Stock Market
- Equities
- INSM Stock
- News Insmed Incorporated
- Goldman Sachs Raises Price Target on Insmed to $102 From $74, Maintains Buy Rating